Granules India share price may fall till Rs 554, know market expert analysis
Granules India Ltd. has been in the spotlight recently due to significant fluctuations in its share price. As of September 12, 2024, the company’s stock was trading at ₹620.65, reflecting a notable decline of 8.63% from the previous closing price. This downturn follows a series of trading sessions marked by volatility, prompting investors and analysts to closely monitor the stock’s performance.
Main Points
On September 12, 2024, Granules India Ltd. opened at ₹620.65, down from ₹679.25 the previous day. The stock has experienced a consistent decline, with its price falling by approximately 5.78% on the same day. Over the past month, the stock has seen a decrease of around 6.69%, while the broader market, represented by the Sensex, has recorded a positive performance of 2.57% during the same period.
Key Metrics
- Current Share Price: ₹620.65
- Previous Closing Price: ₹679.25
- Market Capitalization: Approximately ₹16,465 crore
- 52-Week High/Low: ₹724.55 / ₹306.05
- P/E Ratio: 34.67
- Dividend Yield: 0.21%
These figures indicate that Granules India Ltd. is currently facing challenges, particularly in maintaining its stock price amidst a generally positive market environment.
Varun Beverages share price can remain bullish till Rs 682, know what is the sport level
The technical indicators for Granules India suggest a mixed outlook. The stock is currently trading below its short-term moving averages, indicating a bearish trend. The 5-day and 20-day moving averages are higher than the current price, which may signal continued downward pressure unless a reversal occurs. However, the longer-term moving averages (50-day, 100-day, and 200-day) remain positive, suggesting potential for recovery if the stock can regain momentum.
- Resistance Levels:
- R1: ₹711.43
- R2: ₹719.22
- R3: ₹734.28
- Support Levels:
- S1: ₹688.58
- S2: ₹673.52
- S3: ₹665.73
These levels will be crucial for traders and investors as they navigate the stock’s volatility. A breach of support levels may lead to further declines, while a rally past resistance levels could indicate a potential recovery.
Granules India Ltd. operates in the pharmaceutical sector, primarily focusing on manufacturing generic pharmaceuticals and active pharmaceutical ingredients (APIs). The company has recently reported a decline in sales, with revenue contraction for the first time in three years. This downturn has raised concerns among investors about the company’s future performance and market positioning.
Despite the recent challenges, analysts remain cautiously optimistic. MarketsMOJO has issued a ‘Buy’ recommendation for Granules India, highlighting the company’s potential for growth, especially in the North American market, which has seen increased revenue contributions in recent quarters. The company’s management has expressed confidence in their product diversification strategy, which aims to offset declines in specific segments, such as Paracetamol APIs.
Investor sentiment regarding Granules India Ltd. remains mixed. While some view the recent price drop as an opportunity to buy at a lower price, others are wary of the company’s declining sales figures and overall market performance. The stock’s recent dip has led to increased discussions among analysts and investors about the company’s strategic direction and its ability to navigate current market challenges.
Disclaimer: The information given in this article is from investment experts and brokerage companies, they do not represent Local Haryana. Before taking any investment related decision, you must consult a certified expert.
